Compare PTGX & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | DNUT |
|---|---|---|
| Founded | 2006 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 781.1M |
| IPO Year | 2016 | 2021 |
| Metric | PTGX | DNUT |
|---|---|---|
| Price | $89.03 | $4.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $90.56 | $6.22 |
| AVG Volume (30 Days) | 1.1M | ★ 3.1M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $1,534,272,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $296.47 | $0.77 |
| P/E Ratio | $121.37 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $2.50 |
| 52 Week High | $96.54 | $10.06 |
| Indicator | PTGX | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 48.71 |
| Support Level | $84.11 | $4.35 |
| Resistance Level | $96.54 | $4.72 |
| Average True Range (ATR) | 3.37 | 0.20 |
| MACD | -0.77 | -0.03 |
| Stochastic Oscillator | 44.65 | 9.17 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.